Robert L Rosati

This inventor holds 32 USPTO granted patents and 19 published patent applications, primarily in Pharmaceutical Compounds. Top assignee: Pfizer Corporation. Active years: 1982-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert L Rosati. Retrieved from https://idiyas.com/inventor/robert-l-rosati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 19)

% Patents Active = 75.0

Average Co-Inventor Count = 2.6

ph-index = 11

Forward Citations = 363(Granted Patents)

Location History:

Groton, CT (US) (1990 - 1996)
Stonington, CT (US) (1982 - 2004)
Mystic, CT (US) (2001 - 2009)

Company Filing History:

32 out of 4,486

Pfizer Corporation

patents

Years Active: 1982-2009

Loading Chart...

Areas of Expertise:

Pyrazole Compounds

Prostaglandin Agonists

Estrogen Agonists

Osteoporosis Compounds

Renin Inhibitors

Bone Disorders

Cancer Treatment

Hypertension

Skeletal Disorders

Polypeptides

Carbapenams

Photocatalyzed Process

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7521464 - Pyrazole compounds for treatment of neurodegenerative disorders (2009-04-21),

2. 7442702 - Prostaglandin agonists (2008-10-28),

3. 7238721 - Pyrazole compounds for treatment of neurodegenerative disorders (2007-07-03),

4. RE39558 - 5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosis (2007-04-09),

5. 6998423 - Prevention of loss and restoration of bone mass by certain prostaglandin agonists (2006-02-14),

6. 6821989 - Method of treating certain cancers using an estrogen agonist/antagonist (2004-11-23),

7. 6756388 - Benzothiophenes and related compounds as estrogen agonists (2004-06-29),

8. 6649657 - Prevention of loss and restoration of bone mass by certain prostaglandin agonists (2003-11-18),

9. 6632834 - Compositions and methods for treating conditions responsive to estrogen (2003-10-14),

10. 6498172 - Prostaglandin agonists and their use to treat bone disorders (2002-12-24),

11. 6492412 - Prevention of loss and restoration of bone mass by certain prostaglandin agonists (2002-12-10),

12. 6441193 - Estrogen agonists/antagonists (2002-08-27),

13. 6426359 - Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists (2002-07-30),

14. 6376502 - Osteoporosis compounds (2002-04-23),

15. 6288120 - Prevention of loss and restoration of bone mass by certain prostaglandin agonists (2001-09-11),

Title: Unveiling the Remarkable Innovations of Inventor Robert L Rosati

Introduction:

In the realm of inventors and innovators, Mystic, CT (US) proudly claims one of its own, the esteemed inventor Robert L Rosati. With an impressive portfolio of 32 patents to his name, Robert L Rosati has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative disorders and bone disorders.

Latest Patents:

Among his latest patents, Robert L Rosati has developed groundbreaking inventions such as Pyrazole compounds for the treatment of neurodegenerative disorders. These compounds have shown promising results in inhibiting the production of Aβ-peptide, offering new possibilities in the treatment of diseases like Alzheimer's. Additionally, his invention of prostaglandin agonists for the treatment of bone disorders, including osteoporosis, highlights his commitment to advancing healthcare solutions.

Career Highlights:

Robert L Rosati's innovative work is carried out at Pfizer Corporation, a renowned pharmaceutical company at the forefront of medical research and development. His dedication to creating impactful solutions for challenging medical conditions has earned him recognition in the industry.

Collaborations:

Collaboration plays a vital role in the world of innovation, and Robert L Rosati is no stranger to working alongside talented individuals. Some of his coworkers, including Kimberly O Cameron and Bruce A Lefker, have contributed to the success of his projects, illustrating the power of teamwork in achieving scientific breakthroughs.

Conclusion:

In conclusion, Robert L Rosati stands as a beacon of innovation in the field of pharmaceuticals, with a remarkable track record of patents that have the potential to transform healthcare. His passion for research, coupled with his collaborative spirit, sets a shining example for aspiring inventors and underscores the importance of creativity and teamwork in driving progress.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

19 patents pending: